Risk is not trivial; finding may assist in informed decision making
New research demonstrates that cfDNA methylation patterns may noninvasively identify tumor hypoxia in head and neck squamous cell carcinoma
Program reduces major contour changes and variations in organ-at-risk dosing across health system
Combination therapy demonstrates effectiveness in first-line treatment setting
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Fine-tuning radiation for recurrent cancers
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Cleveland Clinic’s Director, Head and Neck Cancer Research discusses one of her recent projects and the role physician-scientists have in driving medicine forward
Modification of traditional staging factors associated with survival in high-risk disease
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Advertisement
Advertisement